{
  "main_header": {
    "sid": 1292068,
    "name": "Elicio Therapeutics, Inc.",
    "stock_name": "Elicio Therapeutics, Inc.",
    "full_name": "Elicio Therapeutics, Inc.",
    "name_url": "stocks-analysis/elicio-therapeutics-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "8.32",
    "chg": 0.78,
    "chgp": "10.41%",
    "dir": 1,
    "prev_price": "7.54",
    "mcapval": "191.33",
    "mcap": "",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2320,
    "indexname": "S&P 500",
    "isin": "US28657F1030",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "173.26 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/elicio-therapeutics-inc-1292068-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Elicio Therapeutics, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-elicio-therapeutics-inc-technically-bullish-or-bearish-3548742",
        "imagepath": "",
        "date": "2025-09-20 20:24:50",
        "description": "As of 17 June 2025, the technical trend for Elicio Therapeutics, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, and the daily moving averages also indicate a bullish stance. The Bollinger Bands show a bullish signal on the monthly timeframe, while the KST is bullish on both weekly and monthly periods. The stock has demonstrated strong performance year-to-date with a return of 124.8%, significantly outperforming the S&P 500's 12.22% return. Overall, the current technical stance is bullish with strong momentum indicators supporting this view...."
      },
      {
        "title": "Elicio Therapeutics Hits New 52-Week High of $12.61",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/elicio-therapeutics-hits-new-52-week-high-of-1261-3531592",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/ElicioTherapeut_priceRelatedfactors_3531592.png",
        "date": "2025-09-18 13:30:02",
        "description": "Elicio Therapeutics, Inc. achieved a new 52-week high, reflecting strong performance over the past year, significantly outpacing the S&P 500. With a market capitalization of USD 191 million, the company, despite being unprofitable, shows potential in the Pharmaceuticals & Biotechnology sector, emphasizing growth over immediate returns."
      }
    ],
    "total": 6,
    "sid": "1292068",
    "stock_news_url": "https://www.marketsmojo.com/news/elicio-therapeutics-inc-1292068"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is Elicio Therapeutics, Inc. technically bullish or bearish?

2025-09-20 20:24:50

As of 17 June 2025, the technical trend for Elicio Therapeutics, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, and the daily moving averages also indicate a bullish stance. The Bollinger Bands show a bullish signal on the monthly timeframe, while the KST is bullish on both weekly and monthly periods. The stock has demonstrated strong performance year-to-date with a return of 124.8%, significantly outperforming the S&P 500's 12.22% return. Overall, the current technical stance is bullish with strong momentum indicators supporting this view....

Read More

Elicio Therapeutics Hits New 52-Week High of $12.61

2025-09-18 13:30:02

Elicio Therapeutics, Inc. achieved a new 52-week high, reflecting strong performance over the past year, significantly outpacing the S&P 500. With a market capitalization of USD 191 million, the company, despite being unprofitable, shows potential in the Pharmaceuticals & Biotechnology sector, emphasizing growth over immediate returns.

Read More

View All News